絞り込み

18362

広告

「"Willman CL "[Author]」の検索結果

204件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

Integrin α6 mediates drug resistance of acute lymphoblastic B-cell leukemia.

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia.

Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.

Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).

Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.

Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.

Targetable kinase gene fusions in high risk B-ALL: a study from the Children's Oncology Group.

High incidence of philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) in older adults with B-ALL.

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

AACR Cancer Progress Report 2016.

Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
Sort by
※並べ替えは表示に時間がかかります